PHARMACEUTICAL COMBINATION OF Atypical Antipsychotic and NMDA Modulator for the Treatment of Schizophrenia, Bipolar Disorder, Cognitive Disorder and Clinical Depression

• 收藏
• 分享

专利权人:

НОРТВЕСТЕРН ЮНИВЕРСИТИ (US)

发明人:

МОСКАЛ Джозеф Р. (US),МЕЛЬЦЕР Хеберт (US)

申请号：

RU2018116882

公开号：

RU2018116882A

申请日:

2016.10.14

申请国别(地区):

RU

年份:

2019

代理人:

摘要：

This disclosure features combinations of NMDA modulators and atypical antipsychotics. The disclosure provides for example, methods of treating schizophrenia, bipolar disorder, and/or cognitive impairment disorder in a patient in need thereof, comprising administering e.g., rapastinel and an atypical antipsychotic.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/